James Stillman Hanson - General Counsel at G1 Therapeutics, Inc.

Insider Transactions and Holdings

Entity Type
Individual
Role
General Counsel
Issuer Symbol
GTHX
All Insider Reports
All Insider Reports

There are no Buy or Sell transactions made by James Stillman Hanson since 13 Feb 2025

Holdings reported by James Stillman Hanson for G1 Therapeutics, Inc.

Security Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Common Stock 41,087 $120,890 $2.94 05 Jan 2023 Direct
Stock Options (Right to buy) 35,700 03 Jan 2023 Direct Common Stock

Transactions reported by James Stillman Hanson for G1 Therapeutics, Inc.

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.